Literature DB >> 33604796

Cisplatin effect on digital cytomorphometric and bioinformatic tumor cell characteristics in rat ovarian cancer model-a preliminary study.

Nadezhda T Zhilinskaya1,2, Vladimir G Bespalov3,4, Alexander L Semenov3, Elena D Ermakova3,5, Grigory V Tochilnikov3, Nadezhda V Barakova4, Valerii A Alexandrov3, Denis A Baranenko4.   

Abstract

BACKGROUND: Ovarian cancer is one of the most common diseases of the female reproductive system. The aim of this study was the investigation of the antitumor cisplatin effect on ascitic fluid tumor cells in the ovarian cancer experimental model by digital cytomorphometry and cell bioinformatic analysis.
METHODS: Female Wistar rats were inoculated by ovarian cancer strain. After ovarian cancer transplantation rats were divided into two groups: control group-without cisplatin treatment, the experimental group-under cisplatin treatment. The ascitic fluid was taken on the 9-th day after tumor cell inoculation. Digital cytomorphometric and cytobioinformatic analysis were used to study ascitic fluid cancer cell morphofunctional changes under cisplatin treatment.
RESULTS: Digital cytomorphometric characteristics of rat ovarian cancer ascitic cells were obtained. Tumor cells were classified into four groups according to their geometric size: small, medium, large, "gigantic". The algorithm and the computer program based on tumor cell morphometric characteristics were created to calculate such cell bioinformatic characteristic as information redundancy coefficient R. Three parameters were determined as the criteria of cisplatin effect on cancer cells: cell number, nuclear/cytoplasmic ratio, R-value.
CONCLUSIONS: Data obtained suggest that cisplatin reduces the total cell number, the nuclear/cytoplasmic ratio and R-value thus indicates a decrease in cellular resistance and adaptive potential. The digital cytomorphometry and bioinformatics could be recommended as a testing system in the experimental or clinical study.

Entities:  

Keywords:  Apoptosis; Cell bioinformatics; Cisplatin; Digital cytomorphometry; Experimental ovarian cancer

Year:  2021        PMID: 33604796     DOI: 10.1007/s43440-020-00199-8

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  19 in total

Review 1.  Morphology in the Digital Age: Integrating High-Resolution Description of Structural Alterations With Phenotypes and Genotypes.

Authors:  Cynthia C Nast; Kevin V Lemley; Jeffrey B Hodgin; Serena Bagnasco; Carmen Avila-Casado; Stephen M Hewitt; Laura Barisoni
Journal:  Semin Nephrol       Date:  2015-05       Impact factor: 5.299

2.  Classification of cell death: recommendations of the Nomenclature Committee on Cell Death.

Authors:  G Kroemer; W S El-Deiry; P Golstein; M E Peter; D Vaux; P Vandenabeele; B Zhivotovsky; M V Blagosklonny; W Malorni; R A Knight; M Piacentini; S Nagata; G Melino
Journal:  Cell Death Differ       Date:  2005-11       Impact factor: 15.828

3.  Information characteristic of morphology of the adaptational norm, disadaptation, and pathology under the aspect of diagnostic microscopy.

Authors:  G G Avtandilov
Journal:  Gegenbaurs Morphol Jahrb       Date:  1989

4.  Morphological changes in the ovarian carcinoma cells of Wistar rats induced by chemotherapy with cisplatin and dioxadet.

Authors:  A A Zhikhoreva; A V Belashov; V G Bespalov; A L Semenov; I V Semenova; G V Tochilnikov; N T Zhilinskaya; O S Vasyutinskii
Journal:  Biomed Opt Express       Date:  2018-10-29       Impact factor: 3.732

5.  Prediction of lymph node metastases by preoperative nuclear morphometry in oral squamous cell carcinoma: a comparative image analysis study.

Authors:  S Natarajan; S Mahajan; K Boaz; T George
Journal:  Indian J Cancer       Date:  2010 Oct-Dec       Impact factor: 1.224

6.  Experimental study of antitumour activity and effects on leukocyte count of intraperitoneal administration and hyperthermic intraperitoneal chemoperfusion (HIPEC) with dioxadet in a rat model of ovarian cancer.

Authors:  Vladimir Grigorjevich Bespalov; Galina Sergeevna Kireeva; Olesya Alexandrovna Belyaeva; Konstantin Yurjevich Senchik; Alexandr Nikolaevich Stukov; Michail Alexandrovich Maydin; Alexandr Leonidovich Semenov; Georgy Ivanovich Gafton; Konstantin Dzhamiljevich Guseynov; Alexey Mikhailovich Belyaev
Journal:  J Chemother       Date:  2016-06       Impact factor: 1.714

7.  Correlation of microvessel parameters in invasive ductal carcinoma of the breast and fibroadenomas: a morphometric study.

Authors:  Dibyajyoti Boruah; Jasvinder K Bhatia; Abhishek Rai; V Srinivas; V S Nijhawan
Journal:  Ann Diagn Pathol       Date:  2016-09-27       Impact factor: 2.090

8.  Morphometric study of nuclei and microvessels in gliomas and its correlation with grades.

Authors:  Dibyajyoti Boruah; Prabal Deb; V Srinivas; N S Mani
Journal:  Microvasc Res       Date:  2014-03-19       Impact factor: 3.514

9.  Nuclear morphometry and chromatin textural characteristics of basal cell carcinoma.

Authors:  Paola Jung Mendaçolli; Gabrielli Brianezi; Juliano Vilaverde Schmitt; Mariângela Esther Alencar Marques; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.896

10.  Comparative efficacy evaluation of catheter intraperitoneal chemotherapy, normothermic and hyperthermic chemoperfusion in a rat model of ascitic ovarian cancer.

Authors:  Vladimir G Bespalov; Ivan K Alvovsky; Grigory V Tochilnikov; Alexandr N Stukov; Ekaterina A Vyshinskaya; Alexandr L Semenov; Irina N Vasilyeva; Olesya A Belyaeva; Galina S Kireeva; Konstantin Y Senchik; Nadezhda T Zhilinskaya; Julia D Von; Larisa A Krasilnikova; Valery A Alexandrov; Nikita N Khromov-Borisov; Denis A Baranenko; Alexey M Belyaev
Journal:  Int J Hyperthermia       Date:  2017-09-18       Impact factor: 3.914

View more
  1 in total

1.  Downregulation of cell division cycle-associated protein 7 (CDCA7) suppresses cell proliferation, arrests cell cycle of ovarian cancer, and restrains angiogenesis by modulating enhancer of zeste homolog 2 (EZH2) expression.

Authors:  Chunyan Cai; Xing Peng; Yumei Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.